
Sep 25, 2023
EMROK from WOCKHARDT is patented India’s first antibiotic to receive regulatory approval from DCGI for MDR-gram positive infections. The client appr...
Read MoreSep 25, 2023
EMROK from WOCKHARDT is patented India’s first antibiotic to receive regulatory approval from DCGI for MDR-gram positive infections. The client appr...
Read MoreApr 14, 2023
Roche Diabetes Care IMEA is a newly formed Cluster that caters to patients from India, the Middle East, and Africa. Grow IMEA is a concept where Roche...
Read MoreFeb 11, 2022
A Urinary Tract Infection (UTI) can be a severe health condition, seen commonly in women. Often found in the bladder or urethra, although more severe ...
Read MoreApr 14, 2023
Sitagliptin/Mylan and Sitagliptin+Metformin/Mylan, both are classified as DPP-4 inhibitors, promising effective management of the condition....
Read MoreApr 14, 2023
Our team created a scenario-based key visual for a Viatris catalogue featuring a range of generic and prescription medicines which was meticulously cr...
Read MoreApr 17, 2023
The global pharmaceutical brand, Viatris, sought to introduce its acne management cream, Acnacalm, to the Indian market. Our task was to create key vi...
Read MoreApr 17, 2023
Viatris is a global pharmaceutical brand, and Graftix is one of its teams which provides care and support to patients post-organ transplantation throu...
Read MoreFeb 11, 2022
The medication ZYX is known for its effective soothing of throat irritation and pain....
Read MoreJun 12, 2023
Viatris, the global pharmaceutical brand aimed to launch its product Dermoflan in the Indian market. Dermoflan is a medically prescribed Atopic Dermat...
Read MoreJun 12, 2023
Our client, Viatris approached us to recreate a key visual that already being used in the US market. They wanted us to create key visuals which were a...
Read More